Gerry Brunk

Gerry Brunk is a Managing Director at Lumira Ventures and brings over 25 years of investment, consulting and entrepreneurial experience in the health care industry to the Endotronix Board. Prior to joining Lumira Ventures in 2002, Mr. Brunk was an entrepreneur in the life sciences sector, founding and serving in a variety of management and board capacities at several venture capital-funded companies. Earlier in his career he was an engagement manager in the health care practice of The Boston Consulting Group and a member of the investment banking group of Credit Suisse First Boston where his clients included private and public health care companies. Mr. Brunk received his BA from the University of Virginia where he studied biology and economics and his MBA from the Stanford University Graduate School of Business. Mr. Brunk currently sits on the boards of Antios Therapeutics, BardyDx, Cardiac Dimensions, Corvia Medical, HistoSonics and Southeast Life Sciences.